120 related articles for article (PubMed ID: 9550372)
1. Immunostimulatory effects of a plasmid expressing CD40 ligand (CD154) on gene immunization.
Mendoza RB; Cantwell MJ; Kipps TJ
J Immunol; 1997 Dec; 159(12):5777-81. PubMed ID: 9550372
[TBL] [Abstract][Full Text] [Related]
2. Plasmids encoding granulocyte-macrophage colony-stimulating factor and CD154 enhance the immune response to genetic vaccines.
Burger JA; Mendoza RB; Kipps TJ
Vaccine; 2001 Feb; 19(15-16):2181-9. PubMed ID: 11228391
[TBL] [Abstract][Full Text] [Related]
3. Disruption of CD154:CD40 blocks generation of allograft immunity without affecting APC activation.
Shepherd DM; Kerkvliet NI
J Immunol; 1999 Sep; 163(5):2470-7. PubMed ID: 10452982
[TBL] [Abstract][Full Text] [Related]
4. Engineering enhancement of the immune response to HBV DNA vaccine in mice by the use of LIGHT gene adjuvant.
Zhang Y; Jiang W; Fan Y; Wen J; Hao W; Qian M
J Virol Methods; 2008 Nov; 153(2):142-8. PubMed ID: 18722475
[TBL] [Abstract][Full Text] [Related]
5. Antitumor effect of CD40 ligand: elicitation of local and systemic antitumor responses by IL-12 and B7.
Nakajima A; Kodama T; Morimoto S; Azuma M; Takeda K; Oshima H; Yoshino S; Yagita H; Okumura K
J Immunol; 1998 Aug; 161(4):1901-7. PubMed ID: 9712059
[TBL] [Abstract][Full Text] [Related]
6. The preferential induction of a Th1 immune response by DNA-based immunization is mediated by the immunostimulatory effect of plasmid DNA.
Leclerc C; Dériaud E; Rojas M; Whalen RG
Cell Immunol; 1997 Aug; 179(2):97-106. PubMed ID: 9268493
[TBL] [Abstract][Full Text] [Related]
7. Costimulation provided by DNA immunization enhances antitumor immunity.
Corr M; Tighe H; Lee D; Dudler J; Trieu M; Brinson DC; Carson DA
J Immunol; 1997 Nov; 159(10):4999-5004. PubMed ID: 9366427
[TBL] [Abstract][Full Text] [Related]
8. Deoxyribonucleic acid vaccines encoding antigens with rapid proteasome-dependent degradation are highly efficient inducers of cytolytic T lymphocytes.
Wu Y; Kipps TJ
J Immunol; 1997 Dec; 159(12):6037-43. PubMed ID: 9550402
[TBL] [Abstract][Full Text] [Related]
9. Immunostimulatory effects of plasmid DNA and synthetic oligodeoxynucleotides.
Zelenay S; Elías F; Fló J
Eur J Immunol; 2003 May; 33(5):1382-92. PubMed ID: 12731065
[TBL] [Abstract][Full Text] [Related]
10. IL-12 plasmid-enhanced DNA vaccination against carcinoembryonic antigen (CEA) studied in immune-gene knockout mice.
Song K; Chang Y; Prud'homme GJ
Gene Ther; 2000 Sep; 7(18):1527-35. PubMed ID: 11021590
[TBL] [Abstract][Full Text] [Related]
11. The roles of MHC class II, CD40, and B7 costimulation in CTL induction by plasmid DNA.
Chan K; Lee DJ; Schubert A; Tang CM; Crain B; Schoenberger SP; Corr M
J Immunol; 2001 Mar; 166(5):3061-6. PubMed ID: 11207256
[TBL] [Abstract][Full Text] [Related]
12. Protective immunity induced by tumor vaccines requires interaction between CD40 and its ligand, CD154.
Mackey MF; Gunn JR; Ting PP; Kikutani H; Dranoff G; Noelle RJ; Barth RJ
Cancer Res; 1997 Jul; 57(13):2569-74. PubMed ID: 9205055
[TBL] [Abstract][Full Text] [Related]
13. CD40-expressing plasmid induces anti-CD40 antibody and enhances immune responses to DNA vaccination.
Xu H; Zhao G; Huang X; Ding Z; Wang J; Wang X; Cheng Y; Kang Y; Wang B
J Gene Med; 2010 Jan; 12(1):97-106. PubMed ID: 19950201
[TBL] [Abstract][Full Text] [Related]
14. IL-12 up-regulates CD40 ligand (CD154) expression on human T cells.
Peng X; Remacle JE; Kasran A; Huylebroeck D; Ceuppens JL
J Immunol; 1998 Feb; 160(3):1166-72. PubMed ID: 9570530
[TBL] [Abstract][Full Text] [Related]
15. Development of Th1 and Th2 populations and the nature of immune responses to hepatitis B virus DNA vaccines can be modulated by codelivery of various cytokine genes.
Chow YH; Chiang BL; Lee YL; Chi WK; Lin WC; Chen YT; Tao MH
J Immunol; 1998 Feb; 160(3):1320-9. PubMed ID: 9570550
[TBL] [Abstract][Full Text] [Related]
16. Priming for T-cell-mediated rejection of established tumors by cutaneous DNA immunization.
Ross HM; Weber LW; Wang S; Piskun G; Dyall R; Song P; Takechi Y; Nikolić-Zugić J; Houghton AN; Lewis JJ
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2191-6. PubMed ID: 9815614
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of both cellular and humoral responses to genetic immunization by co-administration of an antigen-expressing plasmid and a plasmid encoding the pro-apoptotic protein Bax.
Kinsey BM; Marcelli M; Song L; Bhogal BS; Ittmann M; Orson FM
J Gene Med; 2004 Apr; 6(4):445-54. PubMed ID: 15079819
[TBL] [Abstract][Full Text] [Related]
18. Regulation of T-helper-1 versus T-helper-2 activity and enhancement of tumor immunity by combined DNA-based vaccination and nonviral cytokine gene transfer.
Song K; Chang Y; Prud'homme GJ
Gene Ther; 2000 Mar; 7(6):481-92. PubMed ID: 10757021
[TBL] [Abstract][Full Text] [Related]
19. Intramuscular immunization with a monogenic plasmid DNA tuberculosis vaccine: Enhanced immunogenicity by electroporation and co-expression of GM-CSF transgene.
Zhang X; Divangahi M; Ngai P; Santosuosso M; Millar J; Zganiacz A; Wang J; Bramson J; Xing Z
Vaccine; 2007 Jan; 25(7):1342-52. PubMed ID: 17052817
[TBL] [Abstract][Full Text] [Related]
20. Plasmid DNA vaccines are effective in the absence of IFNgamma.
Hassett DE; Zhang J; Whitton JL
Virology; 1999 Oct; 263(1):175-83. PubMed ID: 10544092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
